Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
RELMADA THERAPEUTICS INC
About RLMD
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing therapies for central nervous system (CNS) and metabolic disorders. The Company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Esmethadone, an isomer of methadone, is a new chemical entity (NCE) that potentially addresses areas of high unmet medical need in the treatment of CNS diseases and other disorders. The Company’s lead program, REL-1017, is a NCE and novel NMDA receptor (NMDAR) channel blocker that preferentially targets hyperactive channels while maintaining physiological glutamatergic neurotransmission. Its lead product candidate, esmethadone, is being developed as a rapidly acting, oral agent for the treatment of depression and other potential indications. Sepranolone is its phase IIb ready neurosteroid developed for the potential treatment of Tourette syndrome and other compulsive disorders.
Find out what a historical investment in RELMADA THERAPEUTICS INC would be worth today using our RLMD stock calculator.
Market Capitalisation
$657.66M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.46M
High today
$6.67
Low today
$6.22
Open price
$6.27
52-week high
$8.00
52-week low
$0.52
Ready to start your investing journey with Stake?
Open an accountHow do I buy RLMD shares in Australia?
Buying RLMD shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in RELMADA THERAPEUTICS INC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in RLMD
What is the ticker symbol of RELMADA THERAPEUTICS INC?
The ticker symbol for RELMADA THERAPEUTICS INC is RLMD.
How much is one share of RLMD?
One share of RLMD is valued at $6.37 as of 10 June 2026.
What is the market capitalisation of RELMADA THERAPEUTICS INC RLMD?
As of 10 June 2026 RELMADA THERAPEUTICS INC has a market cap of $657.66M.
What is the 52-week high for RELMADA THERAPEUTICS INC stock?
The RELMADA THERAPEUTICS INC 52-week high stock price is $8.00.
What is the 52-week low for RELMADA THERAPEUTICS INC stock?
The RELMADA THERAPEUTICS INC 52-week low stock price is $0.52.
Can I buy RLMD shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy RLMD shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in RLMD on Stake
- Buy RLMD from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of RLMD from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
RLMD related stocks